NEOS Shares Outstanding History
Below is a table of the NEOS shares outstanding history going back to 7/23/2015:

Date NEOS Shares Outstanding

Also see: NEOS Market Cap History
NEOS Historical Shares Outstanding:
+27.66% CAGR
NEOS Historical Shares Outstanding: +27.66% CAGR

Mouse over chart for data details
7/23/2015 ...11/2/2020
Neos Therapeutics is a pharmaceutical company. Co.'s approved U.S. Food and Drug Administration (FDA) attention deficit hyperactivity disorder (ADHD) products are: Adzenys extended-release (XR)-orally disintegrating tablet (ODT) (amphetamine) for the treatment of ADHD in patients six years and older; Cotempla XR-ODT (methylphenidate) for the treatment of ADHD in patients six to 17 years old; and Adzenys ER (amphetamine) oral suspension for the treatment of ADHD in patients six years and older. Co.'s clinical-stage asset, NT0502 (N-desethyloxybutynin), is an active metabolite of the active ingredient in DITROPAN® (oxybutynin chloride), an FDA-approved medication for a urological condition. We show 24 historical shares outstanding datapoints in our coverage of NEOS's shares outstanding history.

Understanding the changing numbers of NEOS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NEOS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NEOS by allowing them to research NEOS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for NEOS:
NEOS SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Neos Therapeutics (NEOS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NERV Shares Outstanding History
NK Shares Outstanding History
NKTR Shares Outstanding History
NLNK Shares Outstanding History
NOVN Shares Outstanding History
NSPR Shares Outstanding History
NSTG Shares Outstanding History
NTLA Shares Outstanding History
NTRA Shares Outstanding History
NTRP Shares Outstanding History
More Healthcare companies »


NEOS Shares Outstanding History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.